Sudachitin, a polymethoxylated flavone, improves glucose and lipid metabolism by increasing mitochondrial biogenesis in skeletal muscle

Nutrition and Metabolism

Volumn 11, Issue 1, 2014, Pages

  Tsutsumi, Rie ^a   Yoshida, Tomomi ^a   Nii, Yoshitaka ^b   Okahisa, Naoki ^b   Iwata, Shinya ^b   Tsukayama, Masao ^b   Hashimoto, Rei ^a   Taniguchi, Yasuko ^a   Sakaue, Hiroshi ^a   Hosaka, Toshio ^c   Shuto, Emi ^a   Sakai, Tohru ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Tokushima Prefectural Industrial Technology Center   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Glucose metabolism; Lipid metabolism; Mitochondria; Sudachitin

Indexed keywords

FATTY ACID; FLAVONE DERIVATIVE; OXYGEN; SUDACHITIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; BIOGENESIS; BROWN ADIPOSE TISSUE; CALORIMETRY; CONTROLLED STUDY; DYSLIPIDEMIA; ENERGY EXPENDITURE; ENERGY METABOLISM; FATTY ACID OXIDATION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID METABOLISM; MOUSE; NONHUMAN; OBESITY; SKELETAL MUSCLE; WEIGHT GAIN;

EID: 84905366563     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-11-32     Document Type: Article

References (36)

1. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Kahn SE, Hull RL, Utzschneider KM, Nature 2006 444 840 846 10.1038/nature05482 17167471
2. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, Poirier P, Arterioscler Thromb Vasc Biol 2008 28 1039 1049 10.1161/ATVBAHA.107.159228 18356555
3. Inflammation and lipid signaling in the etiology of insulin resistance. Glass CK, Olefsky JM, Cell Metab 2012 15 635 645 10.1016/j.cmet.2012.04.001 22560216
4. Resveratrol improves health and survival of mice on a high-calorie diet. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA, Nature 2006 444 337 342 10.1038/nature05354 17086191
5. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Mulvihill EE, Allister EM, Sutherland BG, Telford DE, Sawyez CG, Edwards JY, Markle JM, Hegele RA, Huff MW, Diabetes 2009 58 2198 2210 10.2337/db09-0634 19592617
6. Molecular structures of citrus flavonoids determine their effects on lipid metabolism in HepG2 cells by primarily suppressing apoB secretion. Lin Y, Vermeer MA, Bos W, van Buren L, Schuurbiers E, Miret-Catalan S, Trautwein EA, J Agric Food Chem 2011 59 4496 4503 10.1021/jf1044475 21425871
7. Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice. Chanet A, Milenkovic D, Deval C, Potier M, Constans J, Mazur A, Bennetau-Pelissero C, Morand C, Berard AM, J Nutr Biochem 2012 23 469 477 10.1016/j.jnutbio.2011.02.001 21684135
8. Citrus polymethoxylated flavones improve lipid and glucose homeostasis and modulate adipocytokines in fructose-induced insulin resistant hamsters. Li RW, Theriault AG, Au K, Douglas TD, Casaschi A, Kurowska EM, Mukherjee R, Life Sci 2006 79 365 373 10.1016/j.lfs.2006.01.023 16497336
9. Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice. Lee YS, Cha BY, Saito K, Yamakawa H, Choi SS, Yamaguchi K, Yonezawa T, Teruya T, Nagai K, Woo JT, Biochem Pharmacol 2010 79 1674 1683 10.1016/j.bcp.2010.01.034 20144590
10. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. Mulvihill EE, Assini JM, Sutherland BG, DiMattia AS, Khami M, Koppes JB, Sawyez CG, Whitman SC, Huff MW, Arterioscler Thromb Vasc Biol 2010 30 742 748 10.1161/ATVBAHA.109.201095 20110573
11. Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. Do GM, Kwon EY, Kim HJ, Jeon SM, Ha TY, Park T, Choi MS, Biochem Biophys Res Commun 2008 374 55 59 10.1016/j.bbrc.2008.06.113 18611391
12. Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6 J mice. Surwit RS, Seldin MF, Kuhn CM, Cochrane C, Feinglos MN, Diabetes 1991 40 82 87 10.2337/diab.40.1.82 2015977
13. Laboratory animals exhibiting obesity and diabetes syndromes. Herberg L, Coleman DL, Metabolism 1977 26 59 99 10.1016/0026-0495(77)90128-7 834144
14. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM, Hepatology 2007 45 1366 1374 10.1002/hep.21655 17476695
15. Metabolic stress in insulin's target cells leads to ROS accumulation-a hypothetical common pathway causing insulin resistance. Eriksson JW, FEBS Lett 2007 581 3734 3742 10.1016/j.febslet.2007.06.044 17628546
16. Fat poetry: a kingdom for PPAR gamma. Anghel SI, Wahli W, Cell Res 2007 17 486 511 10.1038/cr.2007.48 17563755
17. Regulation of adipocytokines and insulin resistance. Fasshauer M, Paschke R, Diabetologia 2003 46 1594 1603 10.1007/s00125-003-1228-z 14605806
18. Hyperinsulinemia and triglyceride-rich lipoproteins. Steiner G, Lewis GF, Diabetes 1996 45 Suppl 3 24 S26
19. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM, Mol Cell 1999 4 611 617 10.1016/S1097-2765(00)80211-7 10549292
20. Role of the O-linked beta-N-acetylglucosamine in the cardioprotection induced by isoflurane. Hirose K, Tsutsumi YM, Tsutsumi R, Shono M, Katayama E, Kinoshita M, Tanaka K, Oshita S, Anesthesiology 2011 115 955 962 10.1097/ALN.0b013e31822fcede 21876430
21. Nobiletin, a citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in mice. Nakajima A, Yamakuni T, Haraguchi M, Omae N, Song SY, Kato C, Nakagawasai O, Tadano T, Yokosuka A, Mimaki Y, Sashida Y, Ohizumi Y, J Pharmacol Sci 2007 105 122 126 10.1254/jphs.SC0070155 17895593
22. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. Jung UJ, Lee MK, Jeong KS, Choi MS, J Nutr 2004 134 2499 2503 15465737
23. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Wallace DC, Annu Rev Genet 2005 39 359 407 10.1146/annurev.genet.39.110304.095751 16285865
24. Mitochondrial dysfunction in neurodegenerative diseases and cancer. de Moura MB, dos Santos LS, Van Houten B, Environ Mol Mutagen 2010 51 391 405 20544881
25. Aging impairs skeletal muscle mitochondrial bioenergetic function. Figueiredo PA, Powers SK, Ferreira RM, Appell HJ, Duarte JA, J Gerontol A Biol Sci Med Sci 2009 64 21 33 19196905
26. Chronic AMP-activated protein kinase activation and a high-fat diet have an additive effect on mitochondria in rat skeletal muscle. Fillmore N, Jacobs DL, Mills DB, Winder WW, Hancock CR, J Appl Physiol 2010 109 511 520 10.1152/japplphysiol.00126.2010 20522731
27. GPA protects the nigrostriatal dopamine system by enhancing mitochondrial function. Horvath TL, Erion DM, Elsworth JD, Roth RH, Shulman GI, Andrews ZB, Neurobiol Dis 2011 43 152 162 10.1016/j.nbd.2011.03.005 21406233
28. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Morino K, Petersen KF, Shulman GI, Diabetes 2006 55 Suppl 2 9 S15 17130651
29. Metabolic control through the PGC-1 family of transcription coactivators. Lin J, Handschin C, Spiegelman BM, Cell Metab 2005 1 361 370 10.1016/j.cmet.2005.05.004 16054085
30. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM, Cell 1998 92 829 839 10.1016/S0092-8674(00)81410-5 9529258
31. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT, Proc Natl Acad Sci U S A 2009 106 20405 20410 10.1073/pnas.0911570106 19918075
32. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Højlund K, Gygi SP, Spiegelman BM, Nature 2012 481 463 468 10.1038/nature10777 22237023
33. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Hardie DG, Nat Rev Mol Cell Biol 2007 8 774 785 10.1038/nrm2249 17712357
34. The role of AMP-activated protein kinase in mitochondrial biogenesis. Reznick RM, Shulman GI, J Physiol 2006 574 33 39 10.1113/jphysiol.2006.109512 16709637
35. PGC-1alpha regulates a HIF2alpha-dependent switch in skeletal muscle fiber types. Rasbach KA, Gupta RK, Ruas JL, Wu J, Naseri E, Estall JL, Spiegelman BM, Proc Natl Acad Sci U S A 2010 107 21866 21871 10.1073/pnas.1016089107 21106753
36. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, Sinclair DA, Cell Metab 2012 15 675 690 10.1016/j.cmet.2012.04.003 22560220